Hi-Clearance Inc. (TPEX:1788)

Market Cap	6.08B -2.5%
Revenue (ttm)	4.19B +3.3%
Net Income	349.79M -5.5%
EPS	7.85 -5.5%
Shares Out	44.52M
PE Ratio	17.39
Forward PE	n/a
Dividend	7.00 (5.13%)
Ex-Dividend Date	Jun 23, 2025

Volume	15,070
Average Volume	23,450
Open	136.00
Previous Close	136.00
Day's Range	136.00 - 136.50
52-Week Range	130.00 - 146.00
Beta	0.10
RSI	50.25
Earnings Date	Mar 30, 2026

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and servi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1788

Financial Performance

In 2024, Hi-Clearance's revenue was 4.07 billion, an increase of 4.54% compared to the previous year's 3.90 billion. Earnings were 359.69 million, an increase of 3.36%.